Depo Provera Brain Tumor Warning: Why The FDA Changed The Label And What It Means For Users

FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for ...

FDA approves label change for Depo-Provera, adding brain tumor warning

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with the birth control shot.
Becker's Hospital Review

FDA adds brain tumor warning to Depo-Provera label

FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.
Medical Marketing & Media

Pfizer’s birth control injection has a new safety label, reflecting potential brain tumors

The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...
STAT

FDA approves brain tumor warning on Depo-Provera label as court battle grows over side effects

The FDA has approved a change to the labeling for a Pfizer birth control shot that warns patients of the risk of meningioma, ...
Fierce Pharma

Pfizer confirms patient death in Hympavzi hemophilia extension study

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several ...

Patient dies after taking Pfizer’s drug for blood disorder

A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of ...
Nasdaq

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...